文献速递糖尿病

CGM衍生的目标范围内时间与2型糖尿病动脉僵硬度的变化相关

Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2026-06-30

本研究基于前瞻性多中心观察队列,分析348例无心血管症状的2型糖尿病患者基线CGM指标与baPWV纵向变化的关系。中位baPWV在104周和260周分别增加60.1 cm/s和130.3 cm/s。高TIR组与低TIR组baPWV随时间变化存在显著交互作用,且独立于HbA1c。

要点

  • TIR与baPWV纵向变化显著相关,独立于HbA1c。
  • 基线CV、其他CGM指标及HbA1c与baPWV变化无关。
  • baPWV随时间显著增加,提示动脉僵硬度进展。

核心结论

  • 在2型糖尿病患者中,TIR与动脉僵硬度的纵向变化显著相关,且独立于HbA1c。

研究设计与样本

  • 前瞻性、多中心、观察性队列的探索性分析,共纳入348例无有症状心血管疾病史的2型糖尿病患者。
  • 在基线、104周和/或260周进行baPWV测量。
  • 根据基线CGM指标和HbA1c的中位值分组,采用混合效应模型分析基线值与baPWV纵向变化的关系,调整传统动脉粥样硬化危险因素。

主要发现

  • baPWV从基线至104周的中位变化为60.1 cm/s(95% CI: 34.6至85.6),至260周为130.3 cm/s(95% CI: 98.6至162.1),p < 0.001。
  • 在多变量调整模型中,高TIR组与低TIR组之间baPWV随时间变化存在显著交互作用(p = 0.013)。
  • 进一步调整HbA1c后,该交互作用仍显著(p = 0.013)。
  • 基线CV、其他CGM衍生指标及HbA1c与baPWV纵向变化无关。

关键数值与推荐

  • TIR分组依据基线TIR中位值,HbA1c分组依据基线HbA1c中位值。
  • 混合效应模型调整传统动脉粥样硬化危险因素,并进一步调整HbA1c。

临床怎么用

  • 在2型糖尿病血糖管理中,除HbA1c外,可关注CGM衍生的TIR以评估动脉僵硬度进展风险。

局限性

  • 本研究为探索性分析。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines recommend continuous glucose monitoring (CGM) to complement HbA1c in glycemic assessment. While cross-sectional studies have reported associations between CGM-derived metrics and arterial stiffness in type 2 diabetes (T2D), longitudinal evidence remains limited. OBJECTIVE: This study aimed to investigate the longitudinal associations of CGM metrics, particularly time in range (TIR) and coefficient of variation (CV), with changes in brachial-ankle pulse wave velocity (baPWV). METHODS: This exploratory study analyzed data collected over 260 weeks from an ongoing prospective, multicenter, observational cohort. A total of 348 participants with type 2 diabetes and no history of symptomatic cardiovascular disease underwent baPWV measurements at baseline, 104 weeks, and/or 260 weeks. Participants were divided into two groups based on the median values of CGM-derived metrics and HbA1c at baseline, and the associations between each baseline value and longitudinal changes in baPWV were evaluated using mixed-effects models for repeated measures, adjusting for conventional atherosclerotic risk factors. RESULTS: The median change in baPWV from baseline was 60.1 cm/s (95% CI: 34.6 to 85.6) at 104 weeks and 130.3 cm/s (95% CI: 98.6 to 162.1) at 260 weeks (p < 0.001). The change over time in baPWV differed between the higher and lower TIR groups, with a significant interaction between group and time (p = 0.013) in the multivariable-adjusted model. This interaction remained significant even after further adjustment for HbA1c (p = 0.013). In contrast, baseline CV, other CGM-derived metrics, and HbA1c were not associated with longitudinal changes in baPWV. CONCLUSIONS: TIR was significantly associated with longitudinal changes in arterial stiffness in participants with type 2 diabetes, independent of HbA1c.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sato F, Mita T, Katakami N, et al. Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes. J Clin Endocrinol Metab. 2026. PMID: 42375019. doi:10.1210/clinem/dgag261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。